Alexandria Venture Investments, LLC is > 10% Shareholder of Silverback Therapeutics, Inc.. Currently has a direct ownership of 699,412 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on Dec 08, 2020, when has been sold 699,412 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 699K
0% 3M change
0% 12M change
Total Value Held $0

Alexandria Venture Investments, LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 08 2020
BUY
Conversion of derivative security
-
699,412 Added 50.0%
699,412 Common Stock

Also insider at

OMIC
Singular Genomics Systems, Inc. Healthcare
VOR
Vor Biopharma Inc. Healthcare
XLO
Xilio Therapeutics, Inc. Healthcare
VIGL
Vigil Neuroscience, Inc. Healthcare
AVI

Alexandria Venture Investments, LLC

> 10% Shareholder
Pasadena, CA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Track Activities on SBTX